Journey Medical NASDAQ DERM Reports 21 Revenue Growth in Q1 2026 Remains Unprofitable Aspire Bio ASBP Up 066 Is There More Room to Run 20260514 WEBTOON WBTN Declines 752 Amid Market Weakness 20260514